Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance

28 Sept 2013

Abstract excerpt

BACKGROUND: The diagnostic and prognostic value of microRNA (miRNA) expression aberrations in pancreatic ductal adenocarcinoma (PDAC) has been studied extensively in recent years. However, differences in measurement platforms and lab protocols as well as small sample sizes can render gene expression levels incomparable. METHODS: A comprehensive meta-review of published studies in PDAC that compared the miRNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Pancreatic and Hepatic Oncology Research
Share to Pancreatitis Pathology and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24289824
DOI: 10.1186/1756-9966-32-71

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significancePMID 24289824Read ↗

Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell modelsSemantic proximity Read ↗

Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas DataSemantic proximity Read ↗

Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomySemantic proximity Read ↗

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methodsSemantic proximity Read ↗

MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of SurvivalSemantic proximity Read ↗

miRNAs in pancreatic cancer progression and metastasisSemantic proximity Read ↗

Clinical Potential of MicroRNAs in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Experimental Validation of a Potential Circulating microRNA Panel for Non-Invasive Pancreatic Cancer DiagnosisSemantic proximity Read ↗

Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysisSemantic proximity Read ↗

Meta-analysis of 1,200 transcriptomic profiles identifies a prognostic model for pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic valueSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.